On the stock market since 2020, it operates in the world of technology. It has 24 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
An average decline of 34% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executives buying with their own money is usually read as confidence in the company’s future.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
The stock trades 54% below its peak. The market has trimmed its expectations for the company.
Sales run at $267K a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 4 buys and 2 sells. Management buying with its own money is usually read as a good sign.
A loss of $7.9M against $267K in annual sales. And on top of that, sales fell from the year before.
This stock swings about 2.5 times as much as the market average. Big rallies — and big drops — can both happen fast.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, OBTX sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: OBTX is a high-risk stock — not yet profitable, and its future rides on its product catching on.